Close Menu

Informatics

News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.

Informaticians from Georgetown and other major cancer centers expect their technology to bring precision oncology services to community hospitals and clinics.

The company operates three subsidiaries including Helomics, which provides tumor-analysis services for treatment personalization and new drug development.

The Seattle-based firm will use the funding to improve AI integration and further develop its Paris 3D tumor organoid diagnostic and drug discovery platform.

Lantern will use its AI platforms and NCI's omics datasets to identify and validate predictive genomic signatures for drugs it is developing.

The companies will use their respective technologies to identify inhibitors of cancer-associated gene targets and optimize their use as therapeutics.

Oct
23

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.